Janux Therapeutics, Inc.
NASDAQ:JANX
56.83 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash & Cash Equivalents
| 26.754 | 14.662 | 212.803 | 19.205 | 17.152 | 33.703 | 30.355 | 51.426 | 64.752 | 58.403 | 55.129 | 35.582 | 39.389 | 251.625 | 70.769 | 7.813 | -0.658 |
| Short Term Investments
| 631.277 | 631.631 | 438.96 | 324.823 | 332.56 | 269.586 | 286.52 | 275.59 | 274.008 | 295.893 | 306.071 | 339.383 | 348.118 | 142.57 | 0 | 0 | 1.316 |
| Cash and Short Term Investments
| 658.031 | 646.293 | 651.763 | 344.028 | 349.712 | 303.289 | 316.875 | 327.016 | 338.76 | 354.296 | 361.2 | 374.965 | 387.507 | 394.195 | 70.769 | 7.813 | 0.658 |
| Net Receivables
| 0 | 12.056 | 4.405 | 0 | 0 | 0 | 0.75 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0.375 | 0.375 | 8 | 0 |
| Inventory
| 0 | 0 | 0 | -2.2 | -1.7 | -1.5 | 0 | -0.7 | 0 | -0.3 | -0.1 | -0.2 | -0.028 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 8.29 | 3.59 | 2.498 | 5.213 | 5.483 | 6.013 | 3.774 | 5.423 | 4.77 | 3.469 | 3.354 | 1.854 | 2.053 | 2.038 | 0.262 | 0.249 | 0 |
| Total Current Assets
| 666.321 | 661.939 | 658.666 | 349.241 | 355.195 | 309.302 | 321.399 | 332.439 | 344.33 | 358.065 | 364.654 | 377.019 | 389.588 | 396.608 | 71.406 | 16.062 | 0.658 |
| Non-Current Assets: | |||||||||||||||||
| Property, Plant & Equipment, Net
| 25.059 | 26.017 | 26.978 | 27.841 | 28.525 | 28.949 | 29.13 | 29.365 | 29.177 | 26.277 | 2.79 | 1.597 | 1.356 | 0.215 | 0.156 | 0.155 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.816 | 0.816 | 0.816 | 0.816 | 0.816 | 0.816 | 0.816 | 0.816 | 0.816 | 0.816 | 339.383 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.639 | 2.64 | 2.524 | 2.509 | 2.314 | 2.433 | 1.611 | 1.39 | 1.433 | 0.207 | 0.337 | -338.175 | 0.14 | 0 | 0.257 | 0 | -0.658 |
| Total Non-Current Assets
| 28.698 | 29.473 | 30.318 | 31.166 | 31.655 | 32.198 | 31.557 | 31.571 | 31.426 | 27.3 | 3.943 | 2.805 | 1.496 | 0.215 | 0.413 | 0.155 | -0.658 |
| Total Assets
| 695.019 | 691.412 | 688.984 | 380.407 | 386.85 | 341.5 | 352.956 | 364.01 | 375.756 | 385.365 | 368.597 | 379.824 | 391.084 | 396.823 | 71.819 | 16.217 | 0 |
| Liabilities & Equity: | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Account Payables
| 2.462 | 1.253 | 2.254 | 2.424 | 2.505 | 1.91 | 2.051 | 2.159 | 2.866 | 3 | 1.939 | 2.458 | 3.613 | 0.354 | 0.857 | 0.428 | 0 |
| Short Term Debt
| 1.689 | 3.26 | 1.573 | 3.034 | 2.924 | 2.816 | 2.712 | 0.763 | 0 | 0.176 | 0.306 | 0.194 | 0.424 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.094 | 0.972 | 1.705 | 3.648 | 5.34 | 4.935 | 5.406 | 5.906 | 5.371 | 4.649 | 5.163 | 5.264 | 5.065 | 3.646 | 1.95 | 0 |
| Other Current Liabilities
| 13.022 | 6.938 | 5.81 | 5.87 | 5.394 | 7.838 | 6.416 | 8.179 | 7.563 | 4.447 | 5.621 | 4.982 | 3.17 | 3.786 | 2.391 | 2.753 | 0 |
| Total Current Liabilities
| 17.173 | 11.545 | 10.609 | 13.033 | 14.471 | 17.904 | 16.114 | 16.507 | 16.335 | 12.994 | 12.515 | 12.797 | 12.471 | 9.205 | 6.894 | 3.181 | 0 |
| Non-Current Liabilities: | |||||||||||||||||
| Long Term Debt
| 21.742 | 22.19 | 22.612 | 23.025 | 23.431 | 23.82 | 24.184 | 24.542 | 24.092 | 23.268 | 0 | 0 | 0.023 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0.307 | 1.394 | 2.221 | 3.816 | 5.289 | 0 | 0.7 | 1.84 | 2.823 | 4.35 | 6.05 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | -0.307 | -1.394 | -2.221 | -3.816 | -5.289 | 0 | 0 | -1.84 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 77.346 | 21.624 | 0 |
| Total Non-Current Liabilities
| 21.742 | 22.19 | 22.612 | 23.025 | 23.431 | 24.127 | 25.578 | 26.763 | 27.908 | 28.557 | 6.741 | 0.7 | 1.863 | 2.823 | 81.696 | 27.674 | 0 |
| Total Liabilities
| 38.915 | 33.735 | 33.221 | 36.058 | 37.902 | 42.031 | 41.692 | 43.27 | 44.243 | 41.551 | 12.515 | 13.497 | 14.334 | 12.028 | 88.59 | 30.855 | 0 |
| Equity: | |||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 391.084 | 396.823 | 77.346 | 21.624 | 3.996 |
| Common Stock
| 0.052 | 0.052 | 0.051 | 0.046 | 0.046 | 0.042 | 0.042 | 0.042 | 0.042 | 0.042 | 0.041 | 0.041 | 0.041 | 0.041 | 0.001 | 0.001 | 0 |
| Retained Earnings
| -217.541 | -189.482 | -183.523 | -168.763 | -157.005 | -145.437 | -127.929 | -110.47 | -94.405 | -77.709 | -60.821 | -47.411 | -33.995 | -23.229 | -17.023 | -14.739 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 7.831 | -1.616 | -0.524 | 0.665 | -1.175 | -1.06 | -0.739 | -1.535 | -2.277 | -1.907 | -1.567 | -0.27 | 0.024 | 0.017 | -0 | 0 | -7.944 |
| Other Total Stockholders Equity
| 865.762 | 848.723 | 839.759 | 512.401 | 507.082 | 445.924 | 439.89 | 432.703 | 428.153 | 423.388 | 418.429 | 413.967 | 410.68 | 407.966 | -77.346 | -21.624 | 0 |
| Total Shareholders Equity
| 656.104 | 657.677 | 655.763 | 344.349 | 348.948 | 299.469 | 311.264 | 320.74 | 331.513 | 343.814 | 356.082 | 366.327 | 376.75 | 384.795 | -16.771 | -14.638 | -3.948 |
| Total Equity
| 656.104 | 657.677 | 655.763 | 344.349 | 348.948 | 299.469 | 311.264 | 320.74 | 331.513 | 343.814 | 356.082 | 366.327 | 376.75 | 384.795 | -16.771 | -14.638 | -3.948 |
| Total Liabilities & Shareholders Equity
| 695.019 | 691.412 | 688.984 | 380.407 | 386.85 | 341.5 | 352.956 | 364.01 | 375.756 | 385.365 | 368.597 | 379.824 | 391.084 | 396.823 | 71.819 | 16.217 | -3.948 |